These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1982192)

  • 21. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
    Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
    Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
    Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
    Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
    Kharasch ED; Hoffer C; Walker A; Sheffels P
    Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of nifedipine absorption from GITS tablets: comparison of single-dose pharmacokinetics using 10, 20, 40 and 60 mg nifedipine.
    Tateishi T; Okumura K; Orii Y; Tanaka T
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):58-62. PubMed ID: 14756389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
    Chung M; Reitberg DP; Gaffney M; Singleton W
    Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of nifedipine after oral administration in chronic liver disease.
    Ene MD; Roberts CJ
    J Clin Pharmacol; 1987 Dec; 27(12):1001-4. PubMed ID: 3437063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal function.
    Kirch W; Nokhodian A; Halabi A; Weidinger G
    Eur J Drug Metab Pharmacokinet; 1992; 17(1):33-8. PubMed ID: 1499595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this.
    He JX; Ohno K; Tang J; Hattori M; Tani T; Akao T
    J Pharm Pharmacol; 2014 Nov; 66(11):1623-30. PubMed ID: 24961584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and metabolism of nifedipine.
    Raemsch KD; Sommer J
    Hypertension; 1983; 5(4 Pt 2):II18-24. PubMed ID: 6862586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans.
    Qureshi S; Laganière S; Caillé G; Gossard D; Lacasse Y; McGilveray I
    Pharm Res; 1992 May; 9(5):683-6. PubMed ID: 1608903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of nifedipine slow release tablet in Mexican subjects: further evidence for an oxidation polymorphism.
    Hoyo-Vadillo C; Castañeda-Hernández G; Herrera JE; Vidal-Gárate J; Moreno-Ramos A; Chávez F; Hong E
    J Clin Pharmacol; 1989 Sep; 29(9):816-20. PubMed ID: 2808746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.
    Joffe P; Larsen FS; Pedersen V; Ring-Larsen H; Aaes-Jørgensen T; Sidhu J
    Eur J Clin Pharmacol; 1998 May; 54(3):237-42. PubMed ID: 9681666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
    Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
    Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the absolute bioavailability of nifedipine.
    Rashid TJ; Martin U; Clarke H; Waller DG; Renwick AG; George CF
    Br J Clin Pharmacol; 1995 Jul; 40(1):51-8. PubMed ID: 8527268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.